Cargando…

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019

The management and effectiveness of the treatment of Helicobacter pylori infection are heterogeneous worldwide, despite the publication of international consensus conferences and guidelines, which have been widely available for years. The aim of the study was to describe the clinical management and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ariño Pérez, Inés, Martínez-Domínguez, Samuel J., Alfaro Almajano, Enrique, Carrera-Lasfuentes, Patricia, Lanas, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171584/ https://www.ncbi.nlm.nih.gov/pubmed/35625342 http://dx.doi.org/10.3390/antibiotics11050698

Ejemplares similares

Evaluation of Different Strategies to Improve the Management of Helicobacter pylori Infection at the Primary Care Level: Training Sessions Increase Prescription Appropriateness of Treatment Regimens
por: Alfaro, Enrique, et al.
Publicado: (2022)

Diagnosis and Treatment of Helicobacter pylori Infection in Real Practice—New Role of Primary Care Services in Antibiotic Resistance Era
por: Alfaro, Enrique, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain
por: Caldas, María, et al.
Publicado: (2020)

Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer
por: Hernandez-Ainsa, Maria, et al.
Publicado: (2022)

Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients
por: Navarro, Mercedes, et al.
Publicado: (2019)

Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2021)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Evidence-Based Selection on the Appropriate FIT Cut-Off Point in CRC Screening Programs in the COVID Pandemic
por: Aznar-Gimeno, Rocío, et al.
Publicado: (2021)

Two-component regulatory systems in Helicobacter pylori and Campylobacter jejuni: Attractive targets for novel antibacterial drugs
por: Casado, Javier, et al.
Publicado: (2022)

Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019)

CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate
por: Ferrández, Angel, et al.
Publicado: (2006)

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
por: Gargallo, Carla J., et al.
Publicado: (2018)

Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Helicobacter pylori : revisión bibliográfica
por: Gómez Morayta, Enrique
Publicado: (2003)

Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020)

Comparison of the management of Helicobacter pylori infection between the older and younger European populations
por: Jonaitis, Paulius, et al.
Publicado: (2023)

Small Molecule Inhibitors of the Response Regulator ArsR Exhibit Bactericidal Activity against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2020)

Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations
por: Jonaitis, Paulius, et al.
Publicado: (2023)

Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
por: González, Andrés, et al.
Publicado: (2019)

Sero-prevalence of Helicobacter pylori Infection in Neyshabur, Iran, During 2010-2015
por: Salehi, Mohammad, et al.
Publicado: (2017)

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
por: Fernández de Larrea-Baz, Nerea, et al.
Publicado: (2017)

1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2022)

Prevalence of the colonization of Helicobacter pylori among students of the school of dentistry, University of Granada, Spain
por: Liébana, José, et al.
Publicado: (2016)

Helicobacter pylori
por: Harris, A. W. (Adam W.), 1963-
Publicado: (1996)

Helicobacter Pylori
por: Aguilar Lasserre, Rubén
Publicado: (1998)

Helicobacter pylori infection in children
por: Aguilera Matos, Idalmis, et al.
Publicado: (2020)

Role of non-Helicobacter pylori gastric Helicobacters in helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma
por: Lemos, Fabian Fellipe Bueno, et al.
Publicado: (2023)

Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
por: Yang, Ji Yeong, et al.
Publicado: (2021)

Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
por: Irún, Pilar, et al.
Publicado: (2023)

PREVALENCE OF HELICOBACTER PYLORI INFECTION MEASURED WITH URINARY ANTIBODY IN AN URBAN AREA OF JAPAN, 2008–2010
por: TAMURA, TAKASHI, et al.
Publicado: (2012)

Widespread Circulation of Flaviviruses in Horses and Birds in Northeastern Spain (Catalonia) between 2010 and 2019
por: Napp, Sebastian, et al.
Publicado: (2021)

Helicobacter pylori and hormones.
por: Calam, J.
Publicado: (1996)

Helicobacter pylori and dyspepsia.
por: Talley, N. J.
Publicado: (1999)

Helicobacter pylori and apoptosis.
por: Moss, S. F.
Publicado: (1998)

Transmission of Helicobacter pylori
por: Axon, Anthony T. R.
Publicado: (1997)

Management of Helicobacter pylori
por: Shiota, Seiji, et al.
Publicado: (2010)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Helicobacter pylori and Pathogenesis
por: Tomoda, Akio, et al.
Publicado: (2015)

Bacteriophages of Helicobacter pylori
por: Muñoz, Angela B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pni5vdkn7mkphnpl14nsvn42m4